Survival benefit and biomarker of PD‐1 inhibitor combination therapy in first‐line of advanced biliary tract cancer: A retrospective study
出版年份 2023 全文链接
标题
Survival benefit and biomarker of PD‐1 inhibitor combination therapy in first‐line of advanced biliary tract cancer: A retrospective study
作者
关键词
-
出版物
Cancer Medicine
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-06
DOI
10.1002/cam4.6628
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer
- (2023) Ryota Tanaka et al. PLoS One
- Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer
- (2023) Chengpei Zhu et al. Frontiers in Immunology
- Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2023) Robin Kate Kelley et al. LANCET
- Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
- (2023) Xin Qiu et al. Human Vaccines & Immunotherapeutics
- Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
- (2022) Davide Ciardiello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.
- (2022) Do-Youn Oh et al. JOURNAL OF CLINICAL ONCOLOGY
- The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers
- (2022) Roberta Giorgione et al. Immunotherapy
- Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis
- (2022) Qi Jiang et al. Frontiers in Immunology
- Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
- (2022) Sandra Kang et al. Cancers
- The immune modifying effects of chemotherapy and advances in chemo-immunotherapy
- (2022) Daniel R. Principe et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
- (2022) Liwei Ni et al. Frontiers in Nutrition
- 65P A single-arm, open-label, phase II study of tislelizumab combined with lenvatinib and Gemox regimen for conversion therapy of potentially resectable locally advanced biliary tract cancers
- (2022) H. Li ANNALS OF ONCOLOGY
- Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer
- (2022) Dae Won Kim et al. EUROPEAN JOURNAL OF CANCER
- Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma
- (2022) Zhenyun Yang et al. Journal of Inflammation Research
- Blood tests predict the therapeutic prognosis of anti‐PD‐1 in advanced biliary tract cancer
- (2021) Fei Du et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Camrelizumab plus oxaliplatin‐based chemotherapy as first‐line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial
- (2021) Xinni Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
- (2021) Jie Mei et al. Journal of Inflammation Research
- Global incidence of and trends in intrahepatic and extrahepatic cholangiocarcinoma from 1993 to 2012
- (2020) Andrea A. Florio et al. CANCER
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study
- (2020) Liang‐He Lu et al. LIVER INTERNATIONAL
- Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
- (2019) Paola Bertuccio et al. JOURNAL OF HEPATOLOGY
- The Intersection between Tumor Angiogenesis and Immune Suppression
- (2019) Osama E. Rahma et al. CLINICAL CANCER RESEARCH
- Current standards and future perspectives in adjuvant treatment for biliary tract cancers
- (2019) Angela Lamarca et al. CANCER TREATMENT REVIEWS
- Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer
- (2018) Fan Feng et al. BMC GASTROENTEROLOGY
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
- (2017) Stefan Diem et al. LUNG CANCER
- Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis
- (2017) Francesca R. Bertani et al. Scientific Reports
- Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
- (2013) B Goeppert et al. BRITISH JOURNAL OF CANCER
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started